CRON logo

Cronos Group Inc. Stock Price

TSX:CRON Community·CA$1.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 14 Fair Values set on narratives written by author

CRON Share Price Performance

CA$3.61
3.61 (0.00%)
CA$3.45
Fair Value
CA$3.61
3.61 (0.00%)
4.6% overvalued intrinsic discount
CA$3.45
Fair Value
Price CA$3.61
AnalystLowTarget CA$3.45
AnalystConsensusTarget CA$4.24
AnalystHighTarget CA$5.00

CRON Community Narratives

·
Fair Value CA$3.45 4.6% overvalued intrinsic discount

Regulatory Shifts In Israel And Germany Will Hinder Cannabis Growth

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value CA$4.24 14.8% undervalued intrinsic discount

GrowCo Capacity And Global Markets Will Unlock Potential

0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
·
Fair Value CA$5 27.8% undervalued intrinsic discount

Global Cannabis Legalization Will Expand Wellness And Medicine Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CA$4.24
14.8% undervalued intrinsic discount
Profit Margin
11.53%
Future PE
45.83x
Price in 2029
CA$5.08

Trending Discussion

Updated Narratives

CRON logo

CRON: Partial Rescheduling And Brand Execution Will Shape Lean Profit Outlook

Fair Value: CA$3.45 4.6% overvalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CRON logo

CRON: Canadian Brand Strength And Lean Cost Base Will Support Future Upside

Fair Value: CA$4.24 14.8% undervalued intrinsic discount
9 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CRON logo

Global Cannabis Legalization Will Expand Wellness And Medicine Markets

Fair Value: CA$5 27.8% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

0 Risks
2 Rewards

Cronos Group Inc. Key Details

US$159.5m

Revenue

US$95.7m

Cost of Revenue

US$63.8m

Gross Profit

US$65.6m

Other Expenses

-US$1.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.0048
40.00%
-1.14%
0%
View Full Analysis

About CRON

Founded
n/a
Employees
610
CEO
Michael Gorenstein
WebsiteView website
thecronosgroup.com

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Recent CRON News & Updates

Narrative Update May 12

CRON: Partial Rescheduling And Brand Execution Will Shape Lean Profit Outlook

Analysts have lifted their fair value estimate for Cronos Group from CA$3.19 to CA$3.45, citing recent initiation with a CA$4.50 price target and the view that branded positioning, a lean cost base, and potentially favorable regulatory shifts could support higher long term profitability and a lower future P/E assumption. Analyst Commentary Recent commentary around Cronos Group has focused on brand strength, cost discipline, and the potential impact of regulatory changes in key markets.

Recent updates

No updates